Can benzoyl peroxide 10% be used to treat hidradenitis suppurativa?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Benzoyl Peroxide 10% Be Used for Hidradenitis Suppurativa?

Benzoyl peroxide 10% is not recommended as a primary treatment for hidradenitis suppurativa, but it may be used as an adjunctive skin cleanser in combination with topical clindamycin to reduce Staphylococcus aureus resistance risk. 1

Role in HS Treatment Algorithm

Benzoyl peroxide does not appear in any guideline as a standalone therapy for hidradenitis suppurativa. Its use is limited to the following context:

  • Adjunctive cleanser only: The North American Clinical Management Guidelines support the use of benzoyl peroxide as a skin cleanser based on expert opinion, alongside chlorhexidine and zinc pyrithione, but provide no data for specific agents or concentrations. 1

  • Combination with topical clindamycin: When topical clindamycin 1% is prescribed for mild HS (Hurley Stage I), benzoyl peroxide may be added to reduce the risk of Staphylococcus aureus resistance that develops with clindamycin monotherapy. 1, 2

Evidence Quality and Limitations

The evidence supporting benzoyl peroxide in HS is notably weak:

  • No direct efficacy data: No randomized controlled trials or case series have evaluated benzoyl peroxide specifically for hidradenitis suppurativa lesions. 1

  • Extrapolated from acne literature: The recommendation derives from acne vulgaris studies showing that benzoyl peroxide prevents antibiotic resistance when combined with topical antibiotics. 1, 3

  • Expert opinion only: The North American guidelines classify benzoyl peroxide use as supported by expert opinion rather than clinical trial evidence. 1

Practical Application

If you choose to use benzoyl peroxide in a patient with HS:

  • Apply as a wash: Use benzoyl peroxide 10% wash or chlorhexidine 4% wash daily to all affected intertriginous areas. 2

  • Always combine with topical clindamycin: Prescribe topical clindamycin 1% solution or gel twice daily to affected areas for 12 weeks as the primary therapy. 1, 2

  • Limit to Hurley Stage I only: This approach is appropriate only for patients with isolated nodules and abscesses without sinus tracts or scarring. 2

When Benzoyl Peroxide Is Inappropriate

Do not rely on benzoyl peroxide for:

  • Hurley Stage II or III disease: Patients with recurrent abscesses, sinus tracts, or scarring require systemic antibiotics (clindamycin 300 mg + rifampicin 300-600 mg daily for 10-12 weeks) or biologics (adalimumab). 1, 2

  • Inflammatory nodules or abscesses: Benzoyl peroxide has no demonstrated effect on deep inflammatory lesions characteristic of HS. 1

  • Monotherapy: Benzoyl peroxide should never be used alone for HS; it serves only as an adjunct to reduce antibiotic resistance. 1, 2

Evidence-Based First-Line Therapies for HS

Instead of benzoyl peroxide, prioritize guideline-supported treatments:

  • Mild disease (Hurley I): Topical clindamycin 1% twice daily for 12 weeks. 1, 2

  • Moderate disease (Hurley II): Clindamycin 300 mg orally twice daily + rifampicin 300-600 mg daily for 10-12 weeks (71-93% response rate). 1, 2

  • Severe disease (Hurley III): Adalimumab 160 mg week 0,80 mg week 2, then 40 mg weekly starting week 4. 1, 2

Critical Pitfall

The most common error is treating HS like acne vulgaris. While benzoyl peroxide is highly effective for acne 3, 4, 5, hidradenitis suppurativa is a chronic inflammatory disease of the hair follicle requiring systemic anti-inflammatory therapy, not topical antimicrobials alone. 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hidradenitis Suppurativa Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Local wound care and topical management of hidradenitis suppurativa.

Journal of the American Academy of Dermatology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.